ISSN 1612-3352

Editors in Chief

Prof. Dr. Claus F. Claussen, Neurootological Research Institute of the Research Society for Smell, Taste, Hearing and Equilibrium Disorders at Bad Kissingen (4-G-F). Bad Kissingen, Germany.
Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Production Managers

Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.


Associated Editors


The editors welcome authors to submit articles for publications in the ASN.

Read the Information for Authors.


Kurhausstraße 12
D-97688 Bad Kissingen
Germany
Telefon +49-971-6 4832
Fax +49- 971- 6 8637
Email asn@neurootology.org

 

Archived under the topic

Pharmacotherapy

Experiences of treatment of sever type of tinnitus

Sever type of tinnitus is very hard to treat because tinnitus is highly inked to emotional system, the limbic system. To treat it, therefore, all means such as life style intervention, consultation, medication, doctor’s rich successful experience and relaxation should be used. External electrical stimulation may be one of relaxation therapy and tinntius relieved once [...]


Current trends of neurootological pharmacotherapy

Major neurootological complaints, which mostly need drug treatment, are: giddiness,
dizziness, hearing loss and tinnitus. The neurootological differential diagnosis is the basis
for planning the mostly supportive treatment of vertigo patients. In planning the therapy, we
are utilizing a computerbased expert system CLAMEDEX for establishing the
neurootological diagnosis through history, ORL inspection, ENG, calorics, rotatory chair test,
cranio-corpo-graphy (CCG), optokinetics, [...]


Manual medicine in the treatmento of vertigo


The use of antiserotonin drugs in the nucleo-reticular vestibular syndrome and vestibular neuronitis

Vestibular Neuronitis was described in 1949 and 1952 by Dix and Hallpike. Two groups of patients were described, those with sudden seizures and sensations of blackout (since identified as having Vestibular Neuritis) and a second group with symptoms of disequilibrium and feelings of top heaviness or imbalance. The pathology was felt to be central to [...]


Neurootological diagnoses and treatment in cyprus

Two years ago the Vertigo Clinic started to operate in Limassol.
The aim of authors’ investigations is researching vertigo-producing factors in Cypriot patients, and to follow up the results of our treatment protocols.
During the last two years examination of 196 vertiginous patients was performed. The patients’ case history was documented by questionnaire, and a complete ENT, [...]


A choice of disease for studying vestibular compensation in man : the betahistine example

The author proposes, as disease for the study of drugs activity on vestibular compensation mechanisms in man, a peripheral labyrinthine disease without spontaneous nystagmus of type II or III.
He evaluates the state of compensation by the evolution of static posturography parameters and by the score of Norre’s VHT (vestibular habituation training) during an observation period [...]


Treatment of severe meniere´s disease using gentamycine and betamethazone labyrinth perfusion

For Meniere`s Disease (M.D.) patients, we are using Betahistin as standard therapy & additionally Urea or Acetazolamide for the attack periods, with good results. But in severe cases of invalidating M.D. causing extensive vertigo, we are using since 6 years labyrinth perfusion by a solution of Gentamycine and Betamethazon.
Methods: After insertion of a large ventilating [...]


Cognitive disorders: diagnosis and treatment

During the last half century, medical developments have expedited an increase of expectation of life, all over the world.
This extension of life has made that some pathologies that in former years were considered of low prevalence, nowadays they have become top priority for public health.


The early kinetics of gentamicin uptake into the inner ear

Transtympanic gentamicin administration has become a popular modality in the treatment of Ménière’s disease. This modality and other inner-ear medical therapy are gaining increased clinical and scientific attention.


Gaba – benzodiazepine – chloride receptor – targeted therapy for tinnitus control: preliminary report

Our goal was to attempt to establish neuropharmacological tinnitus control (i.e., relief) with medication directed to restoration of a deficiency in the g-aminobutyric acid – benzodiazepine – chloride receptor in tinnitus patients with a diagnosis of a predominantly central type tinnitus.


Login

Registration

If you are not already registered, please register here for free.

If you are registered but have forgotten your password (or you never had one), click here to recover your password.

Proceedings of

Authors

Archives

2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |

(bi)gital»